JAMA Oncology Author Interviews

By: JAMA Network
Listen for free

  • Summary

  • Interviews with authors of articles from JAMA Oncology. JAMA Oncology is the definitive journal for scientists, clinicians, and trainees in the field of oncology worldwide. Our original, innovative, and timely scientific and educational content provides a deeper understanding of cancer pathogenesis and recent treatment advances for our readers. JAMA Oncology aims to effectively convey the findings of important clinical research, major scientific breakthroughs, actionable discoveries, and state-of-the-art treatment pathways to the oncology community. Our goal is that successful communication of new knowledge will ultimately translate to clinical benefit for people living with and surviving cancer.
    2024 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.
    Show More Show Less
Hygiene & Healthy Living Physical Illness & Disease Science
Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2
Episodes
  • Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

    Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
    Nov 21 2024

    Interview with Hagop Kantarjian, MD, author of Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib: A Phase 1b Randomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib
    Show More Show Less
    19 mins
  • Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma

    Anti–PD-L1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
    Oct 24 2024

    Interview with Maria E. Cabanillas, MD, author of Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma: A Nonrandomized Clinical Trial. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Anti–Programmed Death Ligand 1 Plus Targeted Therapy in Anaplastic Thyroid Carcinoma
    Show More Show Less
    21 mins
  • Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer

    Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
    Sep 5 2024

    Interview with Eileen M. O’Reilly, MD, author of Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer. Hosted by Vivek Subbiah, MD.

    Related Content:

    • Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer
    Show More Show Less
    17 mins

What listeners say about JAMA Oncology Author Interviews

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available